| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome
|
Kruse, Robert L.
|
|
|
3 |
2 |
p.
|
article
|
| 2 |
Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag
|
Brown Jr., Robert S.
|
|
|
3 |
2 |
p.
|
article
|
| 3 |
Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis
|
Wirtz, Theresa H.
|
|
|
3 |
2 |
p.
|
article
|
| 4 |
Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis
|
Spatz, Madeleine
|
|
|
3 |
2 |
p.
|
article
|
| 5 |
Case-finding strategies in non-alcoholic fatty liver disease
|
Boursier, Jerome
|
|
|
3 |
2 |
p.
|
article
|
| 6 |
Cell of origin in biliary tract cancers and clinical implications
|
Moeini, Agrin
|
|
|
3 |
2 |
p.
|
article
|
| 7 |
Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade
|
Kwong, Tsz Tung
|
|
|
3 |
2 |
p.
|
article
|
| 8 |
Contents
|
|
|
|
3 |
2 |
p.
|
article
|
| 9 |
Copyright and information
|
|
|
|
3 |
2 |
p.
|
article
|
| 10 |
Editorial Board page
|
|
|
|
3 |
2 |
p.
|
article
|
| 11 |
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
|
Kudo, Masatoshi
|
|
|
3 |
2 |
p.
|
article
|
| 12 |
Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak
|
Piano, Salvatore
|
|
|
3 |
2 |
p.
|
article
|
| 13 |
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
|
Lazarus, Jeffrey V.
|
|
|
3 |
2 |
p.
|
article
|
| 14 |
From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?
|
Sessa, Anna
|
|
|
3 |
2 |
p.
|
article
|
| 15 |
Gut dysbiosis as a driver in alcohol-induced liver injury
|
Fairfield, Bradley
|
|
|
3 |
2 |
p.
|
article
|
| 16 |
Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States
|
de Avila, Victor
|
|
|
3 |
2 |
p.
|
article
|
| 17 |
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
|
Shepherd, Emma L.
|
|
|
3 |
2 |
p.
|
article
|
| 18 |
Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities
|
Dong, Catherine
|
|
|
3 |
2 |
p.
|
article
|
| 19 |
NAFLD and MAFLD as emerging causes of HCC: A populational study
|
Myers, Shuna
|
|
|
3 |
2 |
p.
|
article
|
| 20 |
NASH-related increases in plasma bile acid levels depend on insulin resistance
|
Grzych, Guillaume
|
|
|
3 |
2 |
p.
|
article
|
| 21 |
Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
|
Shang, Ying
|
|
|
3 |
2 |
p.
|
article
|
| 22 |
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation
|
Burton, Anya
|
|
|
3 |
2 |
p.
|
article
|
| 23 |
Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure
|
Blaya, Delia
|
|
|
3 |
2 |
p.
|
article
|
| 24 |
Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear
|
Nachit, Maxime
|
|
|
3 |
2 |
p.
|
article
|
| 25 |
Real-world experience with obeticholic acid in patients with primary biliary cholangitis
|
D’Amato, Daphne
|
|
|
3 |
2 |
p.
|
article
|
| 26 |
Reply to: "Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear"
|
Linge, Jennifer
|
|
|
3 |
2 |
p.
|
article
|
| 27 |
TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload
|
Bidault-Jourdainne, Valeska
|
|
|
3 |
2 |
p.
|
article
|
| 28 |
The third year
|
Sherman, Morris
|
|
|
3 |
2 |
p.
|
article
|
| 29 |
Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines
|
Malik, Farihah
|
|
|
3 |
2 |
p.
|
article
|
| 30 |
ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis
|
To, Jeffrey C.
|
|
|
3 |
2 |
p.
|
article
|
Journal description